Aquestive Therapeutics Inc (AQST) — Tangible Net Worth Ratio
Aquestive Therapeutics Inc (AQST) has a Tangible Net Worth Ratio of 98.0% as of December 2018. This metric is calculated by deducting intangible assets ($204.00K) from net assets ($10.08 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See AQST book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Aquestive Therapeutics Inc Tangible Net Worth Ratio (2005–2018)
This chart shows how Aquestive Therapeutics Inc's Tangible Net Worth Ratio has changed across 3 annual periods from 2005 to 2018. As of December 2018, the ratio stands at 98.0%, reflecting net assets of $10.08 Million with intangible assets of $204.00K USD. Also explore AQST net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Aquestive Therapeutics Inc (2005–2018)
The table below presents the year-by-year Tangible Net Worth Ratio for Aquestive Therapeutics Inc from 2005 to 2018, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Aquestive Therapeutics Inc (AQST) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2018 | 98.0% | $10.08 Million | $204.00K | $86.85 Million | ▲ +4.6 pp |
| 2006 | 93.4% | $25.26 Million | $1.66 Million | $27.18 Million | ▲ +34.1 pp |
| 2005 | 59.3% | $4.67 Million | $1.90 Million | $12.31 Million | — |